Aerska
Latest round
- Series A
Last raised
- Feb 2026
Total raised
- $60M
Investors
- 12
About Aerska
Aerska, Inc.Aerska, Inc. was founded in Wilmington, US in 2025 by Jack O'Meara, Stuart Milstein, and David Hardwicke, focusing on the development of RNA medicines for brain-related diseases. In February 2026, Aerska, Inc. Aerska specializes in developing next-generation RNA medicines designed to treat neurological diseases. The company's core offerings utilize RNA interference (RNAi) technologies for targeted delivery of therapeutic RNA to the central nervous system, with applications for Alzheimer's disease and other neurodegenerative conditions. Aerska's solutions cater to healthcare providers, pharmaceutical firms, and research institutions, focusing on enhancing patient outcomes through precision medicine across North America, Europe, and parts of Asia. Aerska's revenue model is built on partnerships with pharmaceutical companies and research institutions in neurological research. Revenue is generated through milestone payments associated with clinical trial successes and potential licensing fees for proprietary delivery systems. Additionally, revenue may come from research agreements where clients, including biotech firms and academic institutions, compensate Aerska for access to its innovative technologies.
Who invested in Aerska
12 investors across 2 rounds
See all investors in Aerska
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Aerska
Who invested in Aerska?
Aerska has 12 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aerska raised?
Aerska has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Aerska last raise money?
Aerska's most recent round on record is a Series A, in Feb 2026.
What does Aerska do?
Aerska is a biotechnology company.
Where is Aerska headquartered?
Aerska is headquartered in Wilmington, US.
Which VCs invest in companies like Aerska?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Aerska's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Aerska? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.